Literature DB >> 17917255

Isobavachalcone, a chalcone constituent of Angelica keiskei, induces apoptosis in neuroblastoma.

Reiko Nishimura1, Keiichi Tabata, Motoki Arakawa, Yoshihisa Ito, Yumiko Kimura, Toshihiro Akihisa, Hisashi Nagai, Atsuko Sakuma, Hideki Kohno, Takashi Suzuki.   

Abstract

Six chalcones from Angelica keiskei KOIDZUMI (Ashitaba in Japanese) and two chalcones from Humulus lupulus L. (hop) were examined for their cytotoxicity in two human neuroblastoma cell lines (IMR-32 and NB-39) and normal cells (primary culture of rat cerebellar granule cells) by [3-(4,5)-dimethyl-2-thiazolyl]-2,5-diphenyl-2H-tetrazolium bromide (MTT) assay. All chalcones exhibited cytotoxicity against neuroblastoma cells, and two of them (isobavachalcone and xanthoangelol H) had no effect on normal cells even at high concentration (10(-4) M) exposure. Typical morphologic features of apoptosis, including cell shrinkage, chromatin condensation, nuclear fragmentation and formation of apoptotic bodies, were observed in isobavachalcone-treated cells by Hoechst 33342 staining. Western blot analysis showed that isobavachalcone significantly reduced pro-caspase-3 and pro-caspase-9, and subsequently increased the level of cleaved caspase-3 and cleaved caspase-9 in both neuroblastoma cell lines. Moreover, Bax was markedly induced by isobavachalcone application. These results suggest that isobavachalcone induces apoptotic cell death in neuroblastoma via the mitochondrial pathway and has no cytotoxicity against normal cells. Therefore, isobavachalcone may be applicable as an efficacious and safe drug for the treatment of neuroblastoma.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17917255     DOI: 10.1248/bpb.30.1878

Source DB:  PubMed          Journal:  Biol Pharm Bull        ISSN: 0918-6158            Impact factor:   2.233


  32 in total

Review 1.  Isobavachalcone: an overview.

Authors:  Victor Kuete; Louis P Sandjo
Journal:  Chin J Integr Med       Date:  2012-07-07       Impact factor: 1.978

2.  Efflux pumps are involved in the defense of Gram-negative bacteria against the natural products isobavachalcone and diospyrone.

Authors:  Victor Kuete; Bathélémy Ngameni; Jean G Tangmouo; Jean-Michel Bolla; Sandrine Alibert-Franco; Bonaventure T Ngadjui; Jean-Marie Pagès
Journal:  Antimicrob Agents Chemother       Date:  2010-02-16       Impact factor: 5.191

3.  Carnosic acid, a rosemary phenolic compound, induces apoptosis through reactive oxygen species-mediated p38 activation in human neuroblastoma IMR-32 cells.

Authors:  Chia-Wen Tsai; Chia-Yuan Lin; Hui-Hsuan Lin; Jing-Hsien Chen
Journal:  Neurochem Res       Date:  2011-08-11       Impact factor: 3.996

4.  New 4-maleamic acid and 4-maleamide peptidyl chalcones as potential multitarget drugs for human prostate cancer.

Authors:  Juan Rodrigues; Claudia Abramjuk; Luis Vásquez; Neira Gamboa; José Domínguez; Bianca Nitzsche; Michael Höpfner; Radostina Georgieva; Hans Bäumler; Carsten Stephan; Klaus Jung; Michael Lein; Anja Rabien
Journal:  Pharm Res       Date:  2010-12-24       Impact factor: 4.200

Review 5.  The role of chalcones in suppression of NF-κB-mediated inflammation and cancer.

Authors:  Vivek R Yadav; Sahdeo Prasad; Bokyung Sung; Bharat B Aggarwal
Journal:  Int Immunopharmacol       Date:  2010-12-22       Impact factor: 4.932

6.  Dietary chalcones with chemopreventive and chemotherapeutic potential.

Authors:  Barbora Orlikova; Deniz Tasdemir; Frantisek Golais; Mario Dicato; Marc Diederich
Journal:  Genes Nutr       Date:  2011-02-04       Impact factor: 5.523

Review 7.  Potential of Central, Eastern and Western Africa Medicinal Plants for Cancer Therapy: Spotlight on Resistant Cells and Molecular Targets.

Authors:  Armelle T Mbaveng; Victor Kuete; Thomas Efferth
Journal:  Front Pharmacol       Date:  2017-06-02       Impact factor: 5.810

8.  Nuclear condensation and cell cycle arrest induced by telomerase siRNA in neuroblastoma cells.

Authors:  Ming-Dar Tsai; Pei-Rong Chen; Lu-Tai Tien; Yu-Jyun Cai; Yih-Jing Lee
Journal:  J Neurooncol       Date:  2012-12-14       Impact factor: 4.130

Review 9.  Molecular targeted approaches to cancer therapy and prevention using chalcones.

Authors:  Danielle D Jandial; Christopher A Blair; Saiyang Zhang; Lauren S Krill; Yan-Bing Zhang; Xiaolin Zi
Journal:  Curr Cancer Drug Targets       Date:  2014       Impact factor: 3.428

Review 10.  Hormetic dietary phytochemicals.

Authors:  Tae Gen Son; Simonetta Camandola; Mark P Mattson
Journal:  Neuromolecular Med       Date:  2008-06-10       Impact factor: 3.843

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.